Acquisition Master Fund Ltd... Net Worth

What's Acquisition Ltd's mailing address?

Acquisition's mailing address filed with the SEC is 601 CARLSON PARKWAY, SUITE 330, MINNETONKA, MN, 55305.

Insiders trading at IGC Pharma Inc

Over the last 17 years, insiders at IGC Pharma Inc have traded over $12,397,736 worth of IGC Pharma Inc stock and bought 1,543,722 units worth $473,972 . The most active insiders traders include Ram Mukunda, Steven Michael Oliveira y Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of $93,624. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth $443,627.

What does IGC Pharma Inc do?

igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments

IGC Pharma Inc executives and stock owners

IGC Pharma Inc executives and other stock owners filed with the SEC include:

• Ram Mukunda,
  Exec. Chairman, Pres & CEO
• Claudia Grimaldi,
  Vice President, Principal Financial Officer
• Claudia Grimaldi,
  VP & Principal Financial Officer
• Richard Prins,
  Independent Chairman of the Board
• Rohit Goel,
  Manager and Principal Accounting Officer
• Dr. Ranga C. Krishna M.D.,
  Sr. Advisor
• Parveen Mukunda,
  Corp. Sec.
• Rohit Goel,
  Sr. Director of Accounting & Principal Accounting Officer
• John Edward Lynch,
  Director
• John Cherin,
  CFO, Treasurer and PAO
• Sudhakar V Shenoy,
  Director
• Ranga C Krishna,
  Director
• Terry L Lierman,
  Director
• Shu Kwong Ngai,
  Interim CFO
• Zwirn & Co., L.P.Zwirn Dani...,
  
• Acquisition Master Fund Ltd...,
  10% owner
• Suhail Nathani,
  Director
• Ag Ubs,
  10% owner
• Steven Michael Oliveira,
  10% owner
• Master Fund Ltd. Nisswa,
  10% owner
• Ram Mukunda,
  CEO
• Strategic Investment Fund A...,
  10% owner
• James P Moran,
  Director